---
title: "AXGN.US (AXGN.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/AXGN.US/news.md"
symbol: "AXGN.US"
name: "AXGN.US"
parent: "https://longbridge.com/en/quote/AXGN.US.md"
datetime: "2026-05-20T18:45:30.764Z"
locales:
  - [en](https://longbridge.com/en/quote/AXGN.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/AXGN.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/AXGN.US/news.md)
---

# AXGN.US (AXGN.US) — Related News

### [Stephens Investment Management Group LLC Acquires New Stake in AxoGen, Inc. $AXGN](https://longbridge.com/en/news/286746770.md)
*2026-05-18T09:31:19.000Z*
> Stephens Investment Management Group LLC acquired a new stake in AxoGen, Inc. (NASDAQ:AXGN) during Q4, purchasing 154,08

### [AxoGen Says Nerve Repair Strategy Intact as Reimbursement Wins Gather Steam](https://longbridge.com/en/news/286437165.md)
*2026-05-14T15:06:59.000Z*
> AxoGen's President and CEO, Michael Dale, affirmed the company's focus on peripheral nerve repair, highlighting recent r

### [Axogen (AXGN) Is Up 10.3% After Raising 2026 Revenue Outlook Despite Wider Q1 Loss – Has The Bull Case Changed?](https://longbridge.com/en/news/285033467.md)
*2026-05-04T06:08:48.000Z*
> Axogen, Inc. reported a Q1 2026 revenue of $61.46 million, up from $48.56 million a year prior, despite a wider net loss

### [Axogen (AXGN) Q1 Loss Of US$0.38 EPS Tests Bullish Margin Improvement Narrative](https://longbridge.com/en/news/284477676.md)
*2026-04-29T02:05:33.000Z*
> Axogen (AXGN) reported Q1 2026 revenue of US$61.5 million with a basic EPS loss of US$0.38, widening its net loss to US$

### [Axogen (AXGN) Q1 2025 Earnings Transcript](https://longbridge.com/en/news/284438650.md)
*2026-04-28T19:35:37.000Z*
> The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of

### [Axogen Q1 Revenue Jumps; Lifts 2026 Revenue Guidance; Stock Up](https://longbridge.com/en/news/284417254.md)
*2026-04-28T15:40:23.000Z*
> Axogen, Inc. (AXGN) reported a 26.6% revenue growth for Q1 2026, reaching $61.46 million, and raised its full-year reven

### [Full Transcript: Axogen Q1 2026 Earnings Call](https://longbridge.com/en/news/284407654.md)
*2026-04-28T14:18:45.000Z*
> Axogen (NASDAQ:AXGN) reported Q1 2026 revenue of $61.5 million, a 26.6% increase from Q1 2025, driven by growth in all t

### [Sector Update: Health Care Stocks Mixed Pre-Bell Tuesday](https://longbridge.com/en/news/284398038.md)
*2026-04-28T13:20:00.000Z*
> Health care stocks showed mixed performance in premarket trading on Tuesday. The State Street Health Care Select Sector